Ignite Creation Date:
2025-12-18 @ 9:34 AM
Ignite Modification Date:
2025-12-18 @ 9:34 AM
Study NCT ID:
NCT00942578
Status:
None
Last Update Posted:
2018-10-11 00:00:00
First Post:
2009-07-18 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer
Sponsor:
Organization:
Raw JSON
{}